DK114289B - Fremgangsmåde til fremstilling af en inaktiveret vaccine mod svinekolera. - Google Patents

Fremgangsmåde til fremstilling af en inaktiveret vaccine mod svinekolera.

Info

Publication number
DK114289B
DK114289B DK196267AA DK196267A DK114289B DK 114289 B DK114289 B DK 114289B DK 196267A A DK196267A A DK 196267AA DK 196267 A DK196267 A DK 196267A DK 114289 B DK114289 B DK 114289B
Authority
DK
Denmark
Prior art keywords
preparation
vaccine against
inactivated vaccine
against swine
swine cholera
Prior art date
Application number
DK196267AA
Other languages
English (en)
Inventor
J Crawford
Original Assignee
Pfizer & Co C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer & Co C filed Critical Pfizer & Co C
Publication of DK114289B publication Critical patent/DK114289B/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/187—Hog cholera virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK196267AA 1966-05-06 1967-04-07 Fremgangsmåde til fremstilling af en inaktiveret vaccine mod svinekolera. DK114289B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US54806066A 1966-05-06 1966-05-06

Publications (1)

Publication Number Publication Date
DK114289B true DK114289B (da) 1969-06-16

Family

ID=24187237

Family Applications (1)

Application Number Title Priority Date Filing Date
DK196267AA DK114289B (da) 1966-05-06 1967-04-07 Fremgangsmåde til fremstilling af en inaktiveret vaccine mod svinekolera.

Country Status (4)

Country Link
US (1) US3456053A (da)
DE (1) DE1617735A1 (da)
DK (1) DK114289B (da)
GB (1) GB1161333A (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU490824A1 (ru) * 1974-08-27 1975-11-05 Институт полиомиелита и вирусных энцефалитов АМН СССР Способ инактивации инфекциозности вирусов
US4305390A (en) * 1975-11-28 1981-12-15 Massachusetts Institute Of Technology Method for generating oxygen in an excited electronic state and inactivation of microorganisms
US4374965A (en) * 1978-08-31 1983-02-22 Ford Motor Company Alkaline resistant organic coatings for corrosion susceptible substrates II
US4374213A (en) * 1978-08-31 1983-02-15 Ford Motor Company Alkaline resistant organic coatings for corrosion susceptible substrates III
US20030215784A1 (en) * 1998-07-21 2003-11-20 Dumont Larry Joe Method and apparatus for inactivation of biological contaminants using photosensitizers
US6258577B1 (en) 1998-07-21 2001-07-10 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using endogenous alloxazine or isoalloxazine photosensitizers
US7049110B2 (en) 1998-07-21 2006-05-23 Gambro, Inc. Inactivation of West Nile virus and malaria using photosensitizers
US7498156B2 (en) 1998-07-21 2009-03-03 Caridianbct Biotechnologies, Llc Use of visible light at wavelengths of 500 to 550 nm to reduce the number of pathogens in blood and blood components
US6277337B1 (en) 1998-07-21 2001-08-21 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6610436B1 (en) * 1998-09-11 2003-08-26 Gore Enterprise Holdings Catalytic coatings and fuel cell electrodes and membrane electrode assemblies made therefrom
US7220747B2 (en) 1999-07-20 2007-05-22 Gambro, Inc. Method for preventing damage to or rejuvenating a cellular blood component using mitochondrial enhancer
US7094378B1 (en) 2000-06-15 2006-08-22 Gambro, Inc. Method and apparatus for inactivation of biological contaminants using photosensitizers
US6268120B1 (en) 1999-10-19 2001-07-31 Gambro, Inc. Isoalloxazine derivatives to neutralize biological contaminants
TW590780B (en) 2000-06-02 2004-06-11 Gambro Inc Additive solutions containing riboflavin
US7648699B2 (en) 2000-06-02 2010-01-19 Caridianbct Biotechnologies, Llc Preventing transfusion related complications in a recipient of a blood transfusion
US7985588B2 (en) 2000-06-02 2011-07-26 Caridianbct Biotechnologies, Llc Induction of and maintenance of nucleic acid damage in pathogens using riboflavin and light
US9044523B2 (en) 2000-06-15 2015-06-02 Terumo Bct, Inc. Reduction of contaminants in blood and blood products using photosensitizers and peak wavelengths of light
US20090023130A1 (en) * 2003-02-28 2009-01-22 Caridianbct Biotechnologies, Llc Prevention of Transfusion Related Acute Lung Injury Using Riboflavin and Light
EP2026839A4 (en) * 2005-12-14 2009-04-01 Univ Oklahoma RNA VIRUS VACCINE AND METHODS
WO2009018309A2 (en) * 2007-08-01 2009-02-05 Caridianbct Biotechnologies, Llc Pathogen inactivation of whole blood
KR20180042167A (ko) * 2015-08-31 2018-04-25 베링거잉겔하임베트메디카게엠베하 선천성 진전을 위한 페스티바이러스 백신

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127317A (en) * 1964-03-31 Product obtained thereby
US1210053A (en) * 1916-03-22 1916-12-26 Maurice J Couret Process of manufacturing a vaccin for the prevention of hog-cholera and product therefrom.
US2225627A (en) * 1937-03-19 1940-12-24 Stokes Machine Co Method for the concentration and preservation of food products and biological substances
US2705696A (en) * 1951-03-30 1955-04-05 American Cyanamid Co Production of antigens
US3269912A (en) * 1963-04-08 1966-08-30 Boehringer & Soehne Gmbh Aluminum oxide depot vaccines

Also Published As

Publication number Publication date
DE1617735A1 (de) 1972-01-05
GB1161333A (en) 1969-08-13
US3456053A (en) 1969-07-15

Similar Documents

Publication Publication Date Title
DK114289B (da) Fremgangsmåde til fremstilling af en inaktiveret vaccine mod svinekolera.
DK133618B (da) Analogifremgangsmåde til fremstilling af 1-hydroxyaryl-2-aminoalkanoler.
DK121454B (da) Fremgangsmåde til fremstilling af en hjælpestofholdig vaccine.
DK119111B (da) Fremgangsmåde til fremstilling af oxazolidinonderivater.
DK111568B (da) Fremgangsmåde til fremstilling af N-alkyl-3,1-benzoxazin-2-oner.
DK112441B (da) Fremgangsmåde til fremstilling af L-lysin.
DK113859B (da) Fremgangsmåde til fremstilling af hydroksamsyrer.
DK117954B (da) Fremgangsmåde til fremstilling af 3-amino-2-cyanoacrylamid.
DK124886B (da) Fremgangsnmåde til fremstilling af 1-hydroxy-benzimidazol-N-oxider.
DK110208C (da) Fremgangsmåde til fremstilling af influenza-vacciner.
DK117559B (da) Fremgangsmåde til fremstilling af køleretisk virkende 2-alkyl-3,3-diphenylakrylsyrer eller disses salte.
DK119939B (da) Fremgangsmåde til fremstilling af tetanus-vaccine.
DK116752B (da) Fremgangsmåde til fremstilling af et injicerbart influenzavaccinepræparat.
DK113866B (da) Fremgangsmåde til fremstilling af somatiske antigenvacciner.
DK115551B (da) Fremgangsmåde til fremstilling af 6-aminouracil-5-carbonamid-N-sulfonamider.
DK123649B (da) Fremgangsmåde til fremstilling af L-lysin.
DK114063B (da) Fremgangsmåde til fremstilling af 1-methyl-2-isopropyl-5-nitro-imidazol.
DK120344B (da) Fremgangsmåde til fremstilling af 5-benzyl-pyrimidiner.
DK121706B (da) Fremgangsmåde til fremstilling af monothioetherglycol.
DK114626B (da) Fremgangsmåde til fremstilling af 2-substitueret-4-amino-5-acylamidometylpyrimidin.
DK120025B (da) Fremgangsmåde til fremstilling af pyridoxal-5-phosphat.
DK124401B (da) Analogifremgangsmåde til fremstilling af benzensulfonylurinstoffer.
DK126378B (da) Analogifremgangsmåde til fremstilling af 17α-acyloxy-9α-chlor-11β-hydroxy-progesteroner.
DK119830B (da) Analogifremgangsmåde til fremstilling af arylsulfonylsemicarbazider.
DK124405B (da) Fremgangsmåde til fremstilling af 2-trifluormethyl- eller 2-pentafluorethyl-benzimidazoler.